MD Anderson's David M. Gershenson, MD, Receives IGCS's Award for Excellence in Gynecologic Oncology

For his myriad clinical, organizational and scientific accomplishments in the field of gynecologic oncology and the health and well-being of women, David M. Gershenson, M.D. has been recognized with the International Gynecology Cancer Society's (IGCS) Award of Excellence. Gershenson, professor and past chair of the Department of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center, received the award at the IGCS's 15th Biennial Meeting in Melbourne, Australia. William J. Hoskins, MD., of Memorial Sloan Kettering, also was honored with the distinction.The IGCS is a not-for-profit, independent organization contributing to the prevention, treatment and study of gynecologic cancer, as well as improvement in the quality of life among women suffering from such diseases throughout the world.In recognizing Dr. Gershenson, the organization notes him as an exemplar in forwarding the scientific knowledge of gynecological cancers, and, more specifically, of the non-epithelial ovarian cancers."Dr. Gershenson's role in the diagnosis and clinical management of these tumors has been of the top level globally. Many around the world, who are also accomplished and knowledgeable in this area, consult him about issues related to the care of women with these tumors," says the IGCS in a press release. "Through his generosity, countless patients beyond MD Anderson have benefited from his wisdom and unique breadth of experience."Gershenson joined the MD ...
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news